CSL Half Year Result - CSL beats expectations & assimilates Novartis flu business
Online Stockbroker
CSL, the blood products and vaccine maker, posted a better than expected 3.8% lift in half year profit to US$718.8 million
For more Reporting Season coverage, please visit (VIEW LINK)
3 topics
1 stock mentioned
CommSec is Australia's leading online broker. CommSec has been committed to providing the best in online trading since 1995. CommSec helps make informed investment decisions with comprehensive market research, free live pricing and powerful...
Expertise
No areas of expertise
CommSec is Australia's leading online broker. CommSec has been committed to providing the best in online trading since 1995. CommSec helps make informed investment decisions with comprehensive market research, free live pricing and powerful...
Expertise
No areas of expertise